Syndax Pharmaceuticals Inc

NASDAQ:SNDX

19.81

+0.50 (+2.59%)

4:08:25 PM EDT: $20.25 +0.44 (+2.22%)

Market Cap (Intraday)	987.76M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.3 Million
Adjusted EPS	-$0.63

See more estimates

10-Day MA	$18.72
50-Day MA	$16.21
200-Day MA	$19.71

See more pivots

Syndax Pharmaceuticals Inc Stock, NASDAQ:SNDX

35 Gatehouse Drive, Building D, Waltham, Massachusetts 02451

United States of America

Phone: +1.781.419.1400

Number of Employees: 43

http://www.syndax.com

Description

Syndax Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of cancer therapies. Its product candidates include SNDX-5613 and SNDX-6352. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in Waltham, MA.